Clinical Trials Directory

Trials / Completed

CompletedNCT04547764

Evaluation of Triple Antibiotic Paste Pulp Therapy Compared to Vitapex in Primary Molars.

Clinical and Radiographic Evaluation of Triple Antibiotic Paste Pulp Therapy Compared to Vitapex Pulpectomy in Non-vital Primary Molars.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
54 (actual)
Sponsor
King Abdulaziz University · Academic / Other
Sex
All
Age
5 Years – 8 Years
Healthy volunteers
Not accepted

Summary

The aim of the study was to compare the clinical and radiographic success of triple antibiotic paste (TAP) which includes (metronidazole, ciprofloxacin, and minocycline) and Vitapex (calcium hydroxide/iodoform paste) for root canal treatment of pulpally involved teeth.

Detailed description

This study evaluated and compared the clinical and radiographic efficacy of non-instrumentation triple antibiotic paste pulp therapy (TAP) versus Vitapex pulpectomy in non-vital primary molars. Healthy 5 to 9 years old children with at least one non-vital primary molar were included in the study. molars were divided based on the subject's cooperation level and parental preference into two groups. In the first group, molars received TAP and in the second group, they received Vitapex pulpectomy followed by a stainless-steel crown. The TAP was freshly prepared and proportioned in equal parts by volume (metronidazole, minocycline, and ciprofloxacin=1:1:1) before the scheduled treatment appointment. The clinical and radiographic examination was performed by two calibrated and trained pediatric dentists at the pre-operative baseline and at the six- and 12-months follow-up visits.

Conditions

Interventions

TypeNameDescription
DRUGtriple antibiotic paste (TAP)root canal treatment of pulpally involved teeth.
DRUGVitapex (calcium hydroxide/iodoform paste)root canal treatment of pulpally involved teeth.

Timeline

Start date
2017-06-01
Primary completion
2018-12-01
Completion
2018-12-30
First posted
2020-09-14
Last updated
2020-09-14

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT04547764. Inclusion in this directory is not an endorsement.